Gilead to start trial of inhaled version of Covid-fighting remdesivir

Healthy volunteers will be recruited this week, the company said, with the hope of getting inhaled remdesivir into Covid patients in August.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.